Related Experiment Video
Updated: Nov 4, 2025

13:18
Understanding Cerebellar Pattern Formation
Published on: November 1, 2007
5.3K
Recent advances in understanding and managing Kallmann syndrome
Du Soon Swee1, Richard Quinton2,3, Roberto Maggi4
1Department of Endocrinology, Singapore General Hospital, Singapore.
Faculty Reviews
|May 28, 2021
Summary
Genetic studies of Kallmann syndrome patients reveal insights into reproductive biology. This review explores new strategies for evidence-based diagnosis and treatment of this complex genetic disorder.
Area of Science:
- Human reproductive biology
- Neuroendocrinology
- Medical genetics
Background:
- Kallmann syndrome involves impaired gonadotropin-releasing hormone (GnRH) secretion, leading to infertility and anosmia.
- GnRH neurons originate in the olfactory placode and migrate to the hypothalamus during embryonic development.
- The genetic basis of Kallmann syndrome is complex and not fully understood, with various genes implicated in GnRH neuron development and migration.
Purpose of the Study:
- To review recent advances in understanding the genetic basis of Kallmann syndrome.
- To discuss challenges in clinical diagnosis and treatment of Kallmann syndrome.
- To explore new strategies for evidence-based, patient-centered medical practice in Kallmann syndrome.
Main Methods:
- Review of genetic investigations in Kallmann syndrome patients and families.
- Analysis of current clinical diagnostic and treatment approaches.
- Examination of emerging strategies for medical practice.
Main Results:
- Genetic investigations have significantly advanced understanding of reproductive biology.
- Inconsistent implementation of timely diagnosis and evidence-based treatment persists.
- Knowledge of the genetic underpinnings of Kallmann syndrome remains incomplete.
Conclusions:
- Further research into the genetic basis of Kallmann syndrome is crucial.
- Standardized diagnostic criteria and treatment protocols are needed.
- A patient-centered approach is essential for improving medical practice in Kallmann syndrome.
Related Concept Videos
Diagnostic and Statistical Manual of Mental Disorders (DSM)
381
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
381
M-Cdk Drives Transition Into Mitosis
5.8K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.8K
Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K
Karyotyping
65.1K
Overview
65.1K
Cystic Fibrosis: Management
299
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
299
Tumor Progression
6.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.8K

